The Cancering Show
In this episode, Dr. JYP talks with , M.D., a USA Health surgical oncologist, about a new groundbreaking cancer treatment for liver tumors called histotripsy. is a non-invasive technology that uses high-intensity sound waves to break up liver tumors without surgery, incisions or long recovery times. Patients go under general anesthesia, and the machine delivers sound waves to the cancer cells while the physician uses imaging to monitor the treatment. Most people go home the same day and recover quickly, needing only over-the-counter pain medication. This treatment works for different types...
info_outlineThe Cancering Show
In this episode, Dr. JYP welcomes back , a seasoned oncologist who specializes in supportive oncology. Dr. Butler shares his journey from humble beginnings and a fascination with science to a career in cancer care, emphasizing the importance of addressing both the physical and emotional needs of patients. He discusses the distinction between palliative and supportive care, advocating for an approach that supports patients throughout their cancer journey — not just at the end of life. Dr. Butler also offers personal insights from his own cancer diagnosis, reflecting on what he has learned...
info_outlineThe Cancering Show
In this episode, Dr. JYP talks with , a surgical oncologist who specializes in melanoma. Dr. Howard explains that not all skin cancers are the same, emphasizing that melanoma is more dangerous compared with basal cell and squamous cell carcinomas. He highlights the importance of detecting melanoma early, as it is the most dangerous form of skin cancer. They discuss surgical and systemic treatment advancements, including the practice of sentinel lymph node biopsy and the game-changing benefits of immunotherapy. Dr. Howard says clinical trials are essential in improving treatment methods and...
info_outlineThe Cancering Show
In this episode, Dr. JYP welcomes , a trained art therapist who works with patients at the USA Health Mitchell Cancer Institute. Margaret delves into her personal journey, from discovering art therapy to implementing it in cancer care in Mobile, Alabama. She describes art therapy as a marriage between art and psychology, emphasizing its benefits for cancer patients in creating hope, reducing anxiety, and bringing purpose to the cancer journey. She shares stories about how art can turn clinical spaces into environments of light and creativity. Sponsored by the , the MCI’s art therapy...
info_outlineThe Cancering Show
In this episode, Dr. JYP welcomes medical oncologist and hematologist Dr. Daisy Escobar to discuss her background and her expertise in cancer diagnosis and treatment. Dr. Escobar shares her journey to the Mitchell Cancer Institute and talks about her family. The conversation focuses on cell-free DNA technology, also known as liquid biopsy, which is used primarily for cancer surveillance and monitoring. Dr. Escobar explains the benefits and limitations of this technology, including how it compares with traditional biopsies and its potential in early cancer detection. The conversation also...
info_outlineThe Cancering Show
In this episode, Dr. JYP and State Health Officer Dr. Scott Harris discuss the intersection of infectious disease and cancer in Alabama. Dr. Harris shares insights into the state's cancer trends, including the impact of delayed screenings during the pandemic, and disparities in cancer outcomes based on geography and race. They discuss the collaborative efforts among state agencies, nonprofits, and medical communities to combat cancer. They also delve into Alabama's strategic initiative, Operation Wipe Out, aimed at eliminating cervical cancer through vaccination, screening, and treatment....
info_outlineThe Cancering Show
In this heartfelt episode of The Cancering Show, Dr. JYP welcomes back Chaplain Kim Crawford Meeks to discuss the complexities of celebrating the holidays while dealing with cancer. They explore the bittersweet nature of the season, emphasizing the importance of modifying expectations, planning ahead, and cherishing moments with loved ones. Chaplain Kim shares practical advice on managing emotions, supporting family members, and including children in celebrations. They also discuss commemorating a loved one who is no longer present, and ensuring everyone feels valued and included. Whether...
info_outlineThe Cancering Show
In this episode, Dr. JYP speaks with Leah Phillips, a nonsmoker diagnosed with stage 4 non-small cell lung cancer in 2019. Leah emphasizes the importance of self-awareness and self-advocacy in health, sharing her journey from initial misdiagnosis to targeted therapy success. Despite an initial prognosis of six to 12 months to live, Leah has surpassed expectations with a targeted drug that led to significant tumor reduction and stability for over four years. Leah discusses her participation in clinical trials, the benefits of multimodal therapy, and her role in the . For more about Leah, see...
info_outlineThe Cancering Show
In this episode, Dr. JYP and guest Susan Crutchfield discuss the complexities of tobacco addiction and strategies for quitting smoking. They highlight the importance of nonjudgmental support, individual motivations ("your why"), and the availability of various medications and therapies. The dangers of vaping, especially among youth, are also covered, emphasizing nicotine's addictive nature and health risks. The Great American Smokeout is promoted as an event that encourages smoking cessation through peer-to-peer engagement. The significance of early lung cancer detection, particularly through...
info_outlineThe Cancering Show
Dr. JYP concludes a three-part series focused on understanding the most common medical reports received by Cancering patients. This episode delves into pathology reports and how patients can use them to better understand their condition. Dr. JYP describes the key elements of pathology reports and defines terms such as "benign," "malignant," “carcinoma,” and “sarcoma.” She discusses how detailed reports from biopsies aid in staging cancer and the implications for treatment options. She reminds listeners that pathology reports should always be discussed with a doctor, and that reviewing...
info_outlineIn this episode, Dr. JYP talks with Dr. Natalie Bath, M.D., a USA Health surgical oncologist, about a new groundbreaking cancer treatment for liver tumors called histotripsy. Histotripsy is a non-invasive technology that uses high-intensity sound waves to break up liver tumors without surgery, incisions or long recovery times. Patients go under general anesthesia, and the machine delivers sound waves to the cancer cells while the physician uses imaging to monitor the treatment. Most people go home the same day and recover quickly, needing only over-the-counter pain medication. This treatment works for different types of liver tumors, including those that have spread from other cancers, and it doesn’t require people to stop blood thinners. Histotripsy is FDA-approved for liver tumors and offers hope for patients who might not have other options. This episode encourages patients to ask their doctors about all possible treatments and to keep learning more about their choices.
3 Key Listener Takeaways
Groundbreaking, Non-Invasive Liver Cancer Treatment
The episode introduces histotripsy, an exciting new technology that uses focused ultrasound waves from outside the body to destroy liver tumors in a non-invasive manner. This innovative approach preserves surrounding liver tissue and offers an option for patients who might not be candidates for surgery.
Eligibility and Patient Benefits
Histotripsy can be used to treat both primary liver cancer and metastatic cancers from other sites. It's especially promising for patients who are not surgical candidates or who are on medications like blood thinners that would otherwise complicate surgery. With minimal recovery — often just a same-day or next-day discharge — patients experience less downtime and can continue other therapies, such as chemotherapy or immunotherapy, without interruption.
Expansion of Treatment Options and Ongoing Research
The episode highlights how histotripsy adds to the arsenal of cancer care, offering hope and additional options, especially for those who previously had few. It is FDA-approved for liver tumors, with ongoing research exploring its use for kidney, prostate, and pancreatic cancers. Patients are encouraged to advocate for themselves, ask about new technologies, and seek out multimodal therapies that combine traditional and emerging treatments for the best possible outcomes.
Show Overview
00:45 Introduction to histotripsy, a groundbreaking, non-invasive treatment for liver tumors
01:26 Meet Dr. Natalie Bath
02:20 First adopter in Alabama
03:15 What patients can expect
04:55 Who is a candidate?
07:49 Benefits of non-invasive treatment
10:45 FDA approved for liver tumors
15:05 Potential uses for histotripsy
16:45 Where to learn more